Jui Dutta-Simmons

Title: Jui Dutta-Simmons: Innovator in Chimeric Antigen Receptor Technology

Introduction

Jui Dutta-Simmons is a prominent inventor based in Cambridge, MA, known for her groundbreaking work in the field of immunotherapy. She has made significant contributions to the development of chimeric antigen receptors (CARs) that enhance the efficacy of immune cells in targeting cancer cells.

Latest Patents

Dutta-Simmons holds a patent for a "Masked chimeric antigen receptor specific to tyrosine-protein kinase like 7 (PTK7) and immune cells expressing such." This innovative patent describes masked CAR constructs that include an extracellular antigen binding domain specific to PTK7, linked to a mask peptide that prevents the binding of the masked CAR to PTK7. The patent also details genetically engineered T cells that express this masked CAR, along with their therapeutic applications.

Career Highlights

Jui Dutta-Simmons is currently associated with Crispr Therapeutics AG, where she continues to advance her research in gene editing and immunotherapy. Her work is pivotal in the ongoing efforts to develop more effective cancer treatments.

Collaborations

Dutta-Simmons collaborates with notable colleagues, including Jason Gary Sagert and Jonathan Alexander Terrett, contributing to a dynamic research environment focused on innovative therapeutic solutions.

Conclusion

Jui Dutta-Simmons is a trailblazer in the field of immunotherapy, with her patented innovations paving the way for future advancements in cancer treatment. Her contributions are vital to the ongoing evolution of therapeutic strategies in medicine.